MDRNA Eyes Second 'Early Collaborative Effort' Before Year-End, Large Alliance in 2010

Meanwhile, work on MDRNA’s liver and bladder cancer programs proceeds apace, and the company continues to expect it will file its first investigational new drug application before the end of next year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.